Rilpivirine HCl
| CAS No. | 700361-47-3 | Cat. No. | BCP13350 |
| Name | Rilpivirine HCl | ||
| Synonyms | Rilpivirine hydrochloride; TMC278; TMC-278; TMC 278; | ||
| Formula | C22H18N6.HCl | M. Wt | 402.89 |
| Description | Rilpivirine, also known as TMC278, is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz. Rilpivirine was approved for use in the United States in May 2011. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Reverse Transcriptase HIV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.